Radiotherapy Combined With GDP With or Without Chidamide in Stage I/II Extranodal Nasal NK/T-cell Lymphoma

NCT04511351 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

76

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: Chidamide

Sponsor

Chinese Academy of Medical Sciences